What is the TRIB stock price prediction for next 2 weeks?

According to our price prediction algorithm,Trinity Biotech plc (TRIB) price will be around $9.82 in the next 2 weeks. This means it will increase by 1.479338842975209 from the last closing price. This prediction may vary from other time period filters for TRIB stock.

What can be the highest Possible price of TRIB stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, TRIB can achieve the highest price of $11.38 which is 17.578874057202945 higher than last closing price. This prediction may vary from other time period filters for TRIB stock.

What can be the lowest Possible price of TRIB stock in next 2 weeks?

As per the forecast and algorithmic analysis, TRIB stock price can be as low as $8.36 which is -13.638156459327794 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for TRIB stock.

Will TRIB stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that TRIB stock will gain1.479338842975209 in the next 2 weeks. This prediction may vary from other time period filters for TRIB stock.

What is TRIB stock last closing price?

Last closing price of TRIB stock was $9.68.

What is TRIB stock price prediction?

TRIB stock price prediction means predicting the future closing prices of TRIB stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of TRIB stock in a certain time period.

How we predict TRIB stock future prices?

If you are searching for TRIB stock forecast, analysis or price prediction, then you might be wondering what Trinity Biotech plc (TRIB) will do in the future. Our TRIB price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This TRIB price prediction will likely answer most of your questions.

How frequent we update TRIB stock predictions?

We are updating the forecasts for the TRIB stock on daily basis.

Is using ML forecasting for TRIB stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for TRIB stock same for all the time periods?

No, the prediction for TRIB stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Trinity Biotech plc Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$9.68-17.05%Since 2 Weeks

Predicted Price$9.821.48%For 2 Weeks

Upper Predicted Price$11.3817.58%For 2 Weeks

Lower Predicted Price$8.36-13.64%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of TRIB will rise by +1.48% over the next 2 Weeks and hit $9.82 by Friday, September 11, 2026. In that time frame, TRIB's share price is expected to range between $8.36 and $11.38.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Sep 11, 2026	8.41	9.84	11.44
Sep 10, 2026	8.36	9.94	11.50
Sep 9, 2026	8.43	9.86	11.45
Sep 8, 2026	8.88	10.41	11.94
Sep 7, 2026	8.30	9.80	11.43
Sep 4, 2026	8.13	9.75	11.26
Sep 3, 2026	8.29	9.85	11.31
Sep 2, 2026	8.21	9.78	11.42
Sep 1, 2026	8.62	10.32	11.91
Aug 31, 2026	8.34	9.72	11.19

TRIB shares fell -0.72% in Friday, August 28, 2026's trading session, dropping from a previous close of $9.75 to move at $9.68. The stock demonstrated notable intraday movement (see TRIB's key stats for a full breakdown), fluctuating between $9.30 and $9.83, a +5.73% trading range. While recent weeks have seen some volatility, TRIB has managed to secure a -13.34% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 6.65K shares changing hands, 4.59K fewer than the previous session. This amounted to $64.40K in total market activity.

Will TRIB Continue Its Upward Trend?

According to analyst ratings and projections for TRIB, Trinity Biotech plc shares are anticipated to increase by +15.39%, potentially reaching $11.44 per share by September 11, 2026. Short-term technical indicators currently suggest a neutral sentiment for TRIB. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 12 positive trading days within the past 30 sessions. Based on the TRIB stock forecast, now is a good time to buy TRIB stock because its current trading price is -1.58% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on TRIB covering social and institutional perspectives.

TRIB Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into TRIB's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 36.49% to 41.44%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 42.80%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 44.81%, maintains a neutral outlook for the long term. Insights into TRIB's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Trinity Biotech Short-Term Forecasts

TRIB Forecast For Next 5 Days

Our algorithm anticipates Trinity Biotech (TRIB) stock could hit $8.38 by Sep 04, 2026. This represents a -13.47% fall from today's price, following a -2.23% change over the past five days.

TRIB Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Trinity Biotech plc (TRIB) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $8.30, which would mean a -14.26% decrease from the current price of $9.68. Projections for this period range from a high of $13.23 to a low of $2.84.

TRIB Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Trinity Biotech's price over the next three months point to a drop. TRIB stock is expected to peak at $17.10 on Sep 02, 2026 before potentially dipping to $0.00 on Nov 30, 2026. On average, TRIB is likely to trade around $2.97 in the coming 90 days.

Trinity Biotech Stock Forecast 2025

Based on our predictive models, Trinity Biotech (TRIB) is expected to trade between $0.00 and $17.10 throughout 2026. This would result in an average price of $2.55, potentially offering investors a -73.66% return from current levels.

Trinity Biotech plc Monthly Forecast 2026–2027

August 2026

According to our latest forecast models, Trinity Biotech plc (TRIB) is positioned to show a strong performance in August 2026. The price is predicted to move between $0.00 and $15.85, settling at an average of $6.09. This could translate to a -37.09% loss.

September 2026

Based on current market signals, Trinity Biotech plc is projected to trend september 2026. We forecast a trading range from $0.00 to $17.10, with a likely average price of $3.60. Investors could expect a potential return of -62.81%.

October 2026

Our predictive algorithms indicate Trinity Biotech plc stock may see a shift in October 2026. The expected range spans $0.00–$15.74, with an average target of $2.54. This represents a cautious outlook and a possible loss of -73.76%.

November 2026

Analyzing established trends, Trinity Biotech plc looks set to move in November 2026. Projections place the stock between $0.00 and $16.70, averaging around $2.61. This suggests a -73.04% loss from current levels.

December 2026

Market indicators suggest Trinity Biotech plc could experience notable changes during December 2026. Prices could fluctuate within $0.00 to $12.96, with a midpoint forecast of $1.35. The stock might deliver a -86.05% loss.

January 2027

Forecasting for January 2027, models estimate that Trinity Biotech plc may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $13.87, averaging $1.82. This signals a cautious trajectory with potential returns around -81.20%.

February 2027

According to our latest forecast models, Trinity Biotech plc (TRIB) is positioned to show a strong performance in February 2027. The price is predicted to move between $0.00 and $13.39, settling at an average of $1.00. This could translate to a -89.67% loss.

March 2027

Based on current market signals, Trinity Biotech plc is projected to trend march 2027. We forecast a trading range from $0.00 to $14.58, with a likely average price of $0.83. Investors could expect a potential return of -91.43%.

April 2027

Our predictive algorithms indicate Trinity Biotech plc stock may see a shift in April 2027. The expected range spans $0.00–$12.88, with an average target of $0.79. This represents a cautious outlook and a possible loss of -91.84%.

May 2027

Analyzing established trends, Trinity Biotech plc looks set to move in May 2027. Projections place the stock between $0.00 and $12.98, averaging around $0.38. This suggests a -96.07% loss from current levels.

June 2027

Market indicators suggest Trinity Biotech plc could experience notable changes during June 2027. Prices could fluctuate within $0.00 to $13.59, with a midpoint forecast of $0.61. The stock might deliver a -93.70% loss.

July 2027

Forecasting for July 2027, models estimate that Trinity Biotech plc may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $12.61, averaging $0.31. This signals a cautious trajectory with potential returns around -96.80%.

August 2027

According to our latest forecast models, Trinity Biotech plc (TRIB) is positioned to show a strong performance in August 2027. The price is predicted to move between $0.00 and $13.47, settling at an average of $0.29. This could translate to a -97.00% loss.

TRIB's history of dividends and stock splits also plays a role in long-term investor confidence.